A highly versatile adaptor protein for the tethering of growth factors to gelatin-based biomaterials
Source abstract
Abstract
In the field of tissue engineering, the tethering of growth factors to tissue scaffolds in an oriented manner can enhance their activity and increase their half-life. We chose to investigate the capture of the basic Fibroblast Growth Factor (bFGF) and the Epidermal Growth Factor (EGF) on a gelatin layer, as a model for the functionalization of collagen-based biomaterials. Our strategy relies on the use of two high affinity interactions, that is, the one between two distinct coil peptides as well as the one occurring between a collagen-binding domain (CBD) and gelatin. We expressed a chimeric protein to be used as an adaptor that comprises one of the coil peptides and a CBD derived from the human fibronectin. We proved that it has the ability to bind simultaneously to a gelatin substrate and to form a heterodimeric coiled-coil domain with recombinant growth factors being tagged with the complementary coil peptide. The tethering of the growth factors was characterized by ELISA and surface plasmon resonance-based biosensing. The bioactivity of the immobilized bFGF and EGF was evaluated by a human umbilical vein endothelial cell proliferation assay and a vascular smooth muscle cell survival assay. We found that the tethering of EGF preserved its mitogenic and anti-apoptotic activity. In the case of bFGF, when captured via our adaptor protein, changes in its natural mode of interaction with gelatin were observed. Statement of significance In an effort to functionalize collagen/gelatin-based biomaterials with growth factors, we have designed an adaptor protein corresponding to a collagen-binding domain fused to a coil peptide. In our strategy, this adaptor protein captures growth factors being tagged with the partner coil peptide in a specific, stable and oriented manner. We have found that the tethering of the Epidermal Growth Factor preserved its mitogenic and anti-apoptotic activity. In the case of the basic Fibroblast Growth Factor, the captured growth factor remained bioactive although its tethering via this adaptor protein modified its natural mode of interaction with gelatin. Altogether this strategy is easily adaptable to the simultaneous tethering of various growth factors.
Source: europepmc · Quality: candidate unverified · Source record ↗
Research context
OpenAlex topics: Collagen: Extraction and Characterization · Angiogenesis and VEGF in Cancer · Hydrogels: synthesis, properties, applications
SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.
References (58)
Show source-provided references
1. Biomedical applications of collagen10.1016/S0378-5173(01)00691-3 ↗
2. Collagen – biomaterial for drug delivery10.1016/S0939-6411(98)00017-4 ↗
3. Collagen-containing scaffolds enhance attachment and proliferation of non-cultured bone marrow multipotential stromal cells10.1002/jor.23070 ↗
4. FDA approved guidance conduits and wraps for peripheral nerve injury: a review of materials and efficacy10.1016/j.injury.2010.12.030 ↗
5. Collagen gel systems for sustained delivery and tissue engineering10.1016/j.addr.2003.08.004 ↗
6. Growth factor delivery: how surface interactions modulate release in vitro and in vivo10.1016/j.addr.2012.03.004 ↗
7. Collagen binding site in collagenase can be determined using the concept of sense-antisense peptide interactions10.1016/S0021-9258(18)42279-X ↗
8. A collagen/gelatin-binding decapeptide derived from bovine propolypeptide of von Willebrand factor10.1021/bi00151a021 ↗
9. A study of the collagen-binding domain of a 116-kDa Clostridium histolyticum collagenase10.1074/jbc.273.6.3643 ↗
10. Affinity study of novel gelatin cell carriers for fibronectin10.1002/mabi.200900043 ↗
11. C.J. Millard, I.D. Campbell, Structural and Functional Characterisation of the Collagen Binding Domain of Fibronectin, 2007.
12. Production of a biologically active epidermal growth factor fusion protein with high collagen affinity10.1093/oxfordjournals.jbchem.a002900 ↗
13. Establishment of a functionally active collagen-binding vascular endothelial growth factor fusion protein in situ10.1161/01.ATV.0000233359.74484.77 ↗
14. A fusion protein of hepatocyte growth factor for immobilization to collagen10.1016/j.biomaterials.2006.12.022 ↗
15. Spatial immobilization of bone morphogenetic protein-4 in a collagen-PLGA hybrid scaffold for enhanced osteoinductivity10.1016/j.biomaterials.2012.05.038 ↗
16. Definition of the native and denatured type II collagen binding site for fibronectin using a recombinant collagen system10.1074/jbc.M113.530808 ↗
17. Interaction of fibronectin and its gelatin-binding domains with fluorescent-labeled chains of type I collagen10.1016/S0021-9258(18)68828-3 ↗
18. Capillary endothelial cells express basic fibroblast growth factor, a mitogen that promotes their own growth10.1038/325257a0 ↗
19. Vascularization effect of basic fibroblast growth factor released from gelatin hydrogels with different biodegradabilities10.1016/S0142-9612(99)00121-0 ↗
20. Recombinant basic fibroblast growth factor accelerates wound healing10.1016/0022-4804(88)90034-0 ↗
21. Induction of pluripotent stem cells from adult human fibroblasts by defined factors10.1016/j.cell.2007.11.019 ↗
22. Effects of eight growth factors on the differentiation of cells derived from human embryonic stem cells10.1073/pnas.97.21.11307 ↗
23. Review of epidermal growth factor receptor biology10.1016/j.ijrobp.2003.11.041 ↗
24. In vitro sorption and desorption of basic fibroblast growth factor from biodegradable hydrogels10.1016/S0142-9612(98)00089-1 ↗
25. Covalently immobilized biosignal molecule materials for tissue engineering10.1039/B708359A ↗
26. Coiled-coil-mediated grafting of bioactive vascular endothelial growth factor10.1016/j.actbio.2013.02.032 ↗
27. The bioactivity and receptor affinity of recombinant tagged EGF designed for tissue engineering applications is defined by the nature and position of the tags10.1089/ten.tea.2008.0037 ↗
28. Designing heterodimeric two-stranded alpha-helical coiled-coils. Effects of hydrophobicity and alpha-helical propensity on protein folding, stability, and specificity10.1074/jbc.M204257200 ↗
29. Construction of multi-functional extracellular matrix proteins that promote tube formation of endothelial cells10.1016/j.biomaterials.2008.04.006 ↗
30. Advances in surface plasmon resonance biosensor analysis10.1016/S0958-1669(99)00054-3 ↗
31. De Crescenzo · J. Mol. Biol. · 2003 · 328 · 117310.1016/S0022-2836(03)00360-7 ↗
32. New ELISA approach based on coiled-coil interactions10.1016/j.jim.2010.09.027 ↗
33. All six modules of the gelatin-binding domain of fibronectin are required for full affinity10.1074/jbc.M212512200 ↗
34. Human fibronectin and MMP-2 collagen binding domains compete for collagen binding sites and modify cellular activation of MMP-210.1016/S0945-053X(02)00032-X ↗
35. Engineering, expression, and renaturation of a collagen-targeted human bFGF fusion protein10.3109/08977190109029115 ↗
36. Differential endothelial migration and proliferation to basic fibroblast growth factor and vascular endothelial growth factor10.3109/08977199609034566 ↗
37. Vascularization and cellularization of collagen scaffolds incorporated with two different collagen-targeting human basic fibroblast growth factors10.1002/jbm.a.31179 ↗
38. Epidermal growth factor tethered through coiled-coil interactions induces cell surface receptor phosphorylation10.1021/bc9001147 ↗
39. Synthetic peptide F2A4-K-NS mimics fibroblast growth factor-2 in vitro and is angiogenic in vivo
40. Enhancing angiogenesis in collagen matrices by covalent incorporation of VEGF10.1007/s10856-006-9684-x ↗
41. Growth factor delivery-based tissue engineering: general approaches and a review of recent developments10.1098/rsif.2010.0223 ↗
42. Local myocardial insulin-like growth factor 1 (IGF-1) delivery with biotinylated peptide nanofibers improves cell therapy for myocardial infarction10.1073/pnas.0602877103 ↗
43. Controlled co-immobilization of EGF and VEGF to optimize vascular cell survival10.1016/j.actbio.2015.10.026 ↗
44. The contribution of DOPA to substrate-peptide adhesion and internal cohesion of mussel-inspired synthetic peptide films10.1002/adfm.201000932 ↗
45. Binding and release of basic fibroblast growth factor from heparinized collagen matrices10.1016/S0142-9612(00)00418-X ↗
46. Mapping the ligand-binding sites and disease-associated mutations on the most abundant protein in the human, type I collagen10.1074/jbc.M110709200 ↗
47. Interaction of the von Willebrand factor (vWF) with collagen. Localization of the primary collagen-binding site by analysis of recombinant vWF a domain polypeptides10.1074/jbc.270.18.10822 ↗
48. Growth factors engineered for super-affinity to the extracellular matrix enhance tissue healing10.1126/science.1247663 ↗
49. Enhancement of the antagonistic potency of transforming growth factor-β receptor extracellular domains by coiled coil-induced homo- and heterodimerization10.1074/jbc.M400655200 ↗
50. Protein detection by Western blot via coiled–coil interactions10.1016/j.ab.2009.12.007 ↗
51. The promotion of angiogenesis by growth factors integrated with ECM proteins through coiled-coil structures10.1016/j.biomaterials.2013.01.067 ↗
52. Improvement of neural stem cell survival in collagen hydrogels by incorporating laminin-derived cell adhesive polypeptides10.1021/bc200481v ↗
53. Additive benefits of chondroitin sulfate and oriented tethered epidermal growth factor for vascular smooth muscle cell survival10.1002/mabi.201300443 ↗
54. Collagen-binding growth factors: production and characterization of functional fusion proteins having a collagen-binding domain10.1073/pnas.95.12.7018 ↗
55. Regeneration of uterine horns in rats by collagen scaffolds loaded with collagen-binding human basic fibroblast growth factor10.1016/j.biomaterials.2011.07.050 ↗
56. Acceleration of bone union after structural bone grafts with a collagen-binding basic fibroblast growth factor anchored-collagen sheet for critical-size bone defects10.1088/1748-6041/9/3/035014 ↗
57. Engineering and application of collagen-binding fibroblast growth factor 2 for sustained release10.1002/jbm.a.34689 ↗
58. Extrahepatic bile duct regeneration in pigs using collagen scaffolds loaded with human collagen-binding bFGF10.1016/j.biomaterials.2012.03.003 ↗